Even when a bioinformatics company has layoffs, bioinformaticists are the last to go. NetGenics recently laid off 29 of its 100-person workforce. CEO Manuel Glynias says cuts were primarily made in the administrative, consultancy, IT, and marketing departments. “Essentially no programmers” were let go, he says.

Glynias blames poor market conditions, which foiled NetGenics’ IPO plans. “We haven’t been able to get the IPO done and it doesn’t look possible for the next quarter or two,” he says.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.